Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease

NCT06359197 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Caffeine Pill
DRUG: Placebo
DEVICE: TASSO+ Device
DEVICE: Finger prick and collection on Whatman Protein 903 Saver Cards
DEVICE: Intravenous Sampling

Sponsor

Hamilton Health Sciences Corporation